Search results for "Hypertension artérielle"

showing 2 items of 2 documents

Changes in blood pressure in a large cohort of elderly individuals: Study 3C

2009

Summary Objective Analysis of changes in blood pressure with a two-year interval, and of factors associated with this change, in a large cohort of elderly individuals. Methods Follow-up of a cohort of 9294 individuals aged 65 years and over recruited from the general population for Study 3C. Changes in blood pressure are defined as the difference in its averages between the inclusion visit and the follow-up visit at 2 years. The factors associated with changes in systolic blood pressure were identified by univariate and multivariate analyses. Results Systolic and diastolic blood pressure decreased on average by 7.60 mmHg and 4.45 mmHg respectively in 7659 individuals included in the study b…

MaleAgingmedicine.medical_specialtyTime FactorsMultivariate analysisRégression vers la moyennePopulationPression artérielleHypertension artériellePredictive Value of TestsAntihypertensive treatmentRegression toward the meanInternal medicineEpidemiologymedicineHumanseducationRegression towards the meanTraitement antihypertenseurAntihypertensive AgentsAgedAged 80 and overeducation.field_of_studybusiness.industryAge FactorsCohortUnivariateReproducibility of ResultsBlood Pressure DeterminationGeneral MedicineCohorteBlood pressureMultivariate AnalysisHypertensionCohortBlood pressureCardiologyFemaleFranceElderly individualbusinessCardiology and Cardiovascular MedicineSujet âgéFollow-Up StudiesCohort studyArchives of Cardiovascular Diseases
researchProduct

Potential of the EPA/DHA 6/1 formulation to prevent endothelial dysfunction and cardiopulmonary remodeling in pulmonary arterial hypertension in rats

2016

Pulmonary arterial hypertension (PAH) is characterized by remodeling of the small pulmonary arteries leading to a progressive increase in pulmonary vascular resistance and right ventricular failure. Pulmonary endothelial dysfunction, inflammation and oxidative stress promote the development of pulmonary hypertension. Omega-3 polyunsaturated fatty acids such as eicosapentaenoic acid (EPA) and docosahexaenoic acids (DHA) have been shown to protect the cardiovascular system and reduce inflammation and oxidative stress. The present study evaluate the potential of EPA:DHA 6:1 to prevent monocrotaline-induced PAH in rats. EPA:DHA 6:1 treatment (500 mg/kg/d, p.o) prevented the MCT-induced mean pul…

MonocrotalineAcide eicosapentaénoîque (EPA)Dysfonction endothélialeInflammation and oxidative stress[CHIM.THER] Chemical Sciences/Medicinal ChemistryDocosahexaenoic acids (DHA)Hypertension artérielle pulmonaireRemodelage pulmonairePulmonary arterial hypertensionAcide docosahexaénoïque (DHA)Remodelage du ventricule droitInflammation et stress oxydant[SDV.SP.PHARMA] Life Sciences [q-bio]/Pharmaceutical sciences/PharmacologyCardiopulmonary remodelinglipids (amino acids peptides and proteins)Pulmonary endothelial dysfunctionEicosapentaenoic acid (EPA)
researchProduct